Showing results (71-80 of 86) with videos related to

Sort By:
Pageof 9
Cell Stem Cell|January 19, 2022
TRAF6 functions as a tumor suppressor in myeloid malignancies by directly targeting MYC oncogenic activityTomoya Muto, Maria Guillamot, Jennifer Yeung, et al.
Cancer Discovery|August 4, 2022
The Impact of Inflammation-Induced Tumor Plasticity during Myeloid TransformationAnna Yeaton, Geraldine Cayanan, Sanam Loghavi, et al.
Blood|April 8, 2026
Genotype-immunophenotype relationships in NPM1-mutated AML clonal evolution uncovered by single-cell multiomic analysisMorgan Drucker, Darren Lee, Michael S Bowman, et al.
Experimental Hematology|July 13, 2015
MicroRNA-223 dose levels fine tune proliferation and differentiation in human cord blood progenitors and acute myeloid leukemiaBernhard Gentner, Nicole Pochert, Arefeh Rouhi, et al.
ACS Medicinal Chemistry Letters|May 14, 2025
IRAK1/4/pan-FLT3 Kinase Inhibitors with Reduced hERG Block as Treatments for Acute Myeloid LeukemiaScott B Hoyt, Chris J Finocchio, Elizabeth Croll, et al.
Science Translational Medicine|September 6, 2019
Overcoming adaptive therapy resistance in AML by targeting immune response pathwaysKatelyn Melgar, Morgan M Walker, LaQuita M Jones, et al.
Blood|June 2, 2011
Comprehensive analysis of mammalian miRNA* species and their role in myeloid cellsFlorian Kuchenbauer, Sarah M Mah, Michael Heuser, et al.
ACS Medicinal Chemistry Letters|November 20, 2024
Discovery of IRAK1/4/pan-FLT3 Kinase Inhibitors as Treatments for Acute Myeloid LeukemiaScott B Hoyt, Chris J Finocchio, Elizabeth Croll, et al.
Blood Advances|February 11, 2026
A novel approach to defining progression in MDS and precursor myeloid conditions in The MDS Natural History StudyAmy E DeZern, Nancy Gillis, Michael Otterstatter, et al.
Leukemia & Lymphoma|May 22, 2019
The National MDS Natural History Study: design of an integrated data and sample biorepository to promote research studies in myelodysplastic syndromesMikkael A Sekeres, Steven D Gore, Donald M Stablein, et al.
Pageof 9